Correlation Between Ascendis Pharma and A1LN34

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ascendis Pharma and A1LN34 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ascendis Pharma and A1LN34 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ascendis Pharma AS and A1LN34, you can compare the effects of market volatilities on Ascendis Pharma and A1LN34 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ascendis Pharma with a short position of A1LN34. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ascendis Pharma and A1LN34.

Diversification Opportunities for Ascendis Pharma and A1LN34

-0.31
  Correlation Coefficient

Very good diversification

The 3 months correlation between Ascendis and A1LN34 is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Ascendis Pharma AS and A1LN34 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on A1LN34 and Ascendis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ascendis Pharma AS are associated (or correlated) with A1LN34. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of A1LN34 has no effect on the direction of Ascendis Pharma i.e., Ascendis Pharma and A1LN34 go up and down completely randomly.

Pair Corralation between Ascendis Pharma and A1LN34

Assuming the 90 days trading horizon Ascendis Pharma AS is expected to generate 1.46 times more return on investment than A1LN34. However, Ascendis Pharma is 1.46 times more volatile than A1LN34. It trades about 0.18 of its potential returns per unit of risk. A1LN34 is currently generating about 0.03 per unit of risk. If you would invest  4,884  in Ascendis Pharma AS on September 24, 2024 and sell it today you would earn a total of  451.00  from holding Ascendis Pharma AS or generate 9.23% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Ascendis Pharma AS  vs.  A1LN34

 Performance 
       Timeline  
Ascendis Pharma AS 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Ascendis Pharma AS are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Ascendis Pharma is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
A1LN34 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days A1LN34 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong essential indicators, A1LN34 is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Ascendis Pharma and A1LN34 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ascendis Pharma and A1LN34

The main advantage of trading using opposite Ascendis Pharma and A1LN34 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ascendis Pharma position performs unexpectedly, A1LN34 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in A1LN34 will offset losses from the drop in A1LN34's long position.
The idea behind Ascendis Pharma AS and A1LN34 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital